抗癌药物cephalotaxinone和homoerythratine的完全生物合成
Complete biosynthesis of the anticancer cephalotaxinone and homoerythratine
Runze Tian, Feifan Lin, Nianxin Guo, Chendi Liu, Kaiqi Chen, Yunxi Han, Ruiyun Lan, Qiang Li, Jianbin Yan, Xiaoguang Lei
Journal:CELL
IF:45.1
DOI:10.1016/j.cell.2026.06.007
PMID:
Published:2026-06-11
research field:天然产物生物合成细胞色素P450酶学代谢工程生物碱化学植物生物化学多组学整合
Abstract
Cephalotaxine-type and homoerythrina-type alkaloids are structurally unique and biologically important natural products isolated from endangered species that belong to the genus Cephalotaxus. Among them, homoharringtonine (HHT [1]) is a marketed drug used to treat leukemia. However, the scalable production of HHT is significantly hindered by limited natural resources. Despite intensive investigation over half a century, the complete biosynthetic pathways of these alkaloids remain unknown. Here, we applied a comprehensive multi-omics analysis and used a set of chemically synthesized standard compounds to identify the missing enzymes required for the biosynthesis of cephalotaxinone and homoerythratine. We also uncovered a rare case of divergent oxidation catalyzed by two highly homologous cytochrome P450 enzymes, CfCYP2 and CfCYP3, in the biosynthesis of two structurally distinct alkaloids. We further identified the key residues that significantly affect the divergent oxidation outcomes and ultimately reconstituted the complete biosynthetic pathways for producing these two alkaloids in N. benthamiana.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


